SEC Form 4 · accession 0001104659-17-072363
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Moscato Jr.
Officer — COO · Director
Period of report
Dec 4, 2017
Accepted (ET)
Dec 7, 2017 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Shares of common stock | Dec 4, 2017 | P | 285 | $1.77 | A | 2,592,743 | I | Family relationship |
Table II — derivative securities
No Table II lines on this filing.